Идёт набор NCT06179524
CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL
Relapsed B-cell Acute Lymphoblastic Leukemia · Refractory B-cell Acute Lymphoblastic Leukemia
CAR-T и клеточная терапия
1 352 исследования в этом разделе
Идёт набор NCT06768151
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Advanced Lung Cancer
Набор по приглашению NCT06763640
Prognostic Value of TIL in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Идёт набор NCT06765564
Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)
ALS
Идёт набор NCT06106906
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Набор скоро начнётся NCT06764537
Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
Glioblastoma
Идёт набор NCT06760260
Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Набор по приглашению NCT06762431
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.
Chronic Lymphocytic Leukaemia (CLL) · Small Lymphocytic Lymphoma (SLL)
Набор скоро начнётся NCT06762119
A Study of CAR-T Cells in Subjects with Autoimmune Diseases
Autoimmune Diseases
Идёт набор NCT06762132
A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
Идёт набор NCT06758713
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
Multiple Myeloma · B-cell Lymphoma · Hematological Malignancy
Идёт набор NCT05054257
CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia · Non-Hodgkin's Lymphoma Refractory · Non-Hodgkin's Lymphoma, Relapsed
Идёт набор NCT06759181
Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
Multiple Myeloma
Идёт набор NCT06756321
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
Relapsed/refractory Lymphoma · Relapsed/Refractory Leukemia
Набор скоро начнётся NCT06485232
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
Neuromyelitis Optica Spectrum Disorders · Myasthenia Gravis, Generalized · Multiple Sclerosis
Идёт набор NCT06752785
CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
Acute Lymphoblastic Leukemia
Идёт набор NCT06554951
Study of Extracellular Vesicles (EV) in Patients Undergoing CAR-T Cell Therapies
CAR-T Cell Therapy · Extracellular Vesicles
Идёт набор NCT05807789
Molecular-genetic Characterization in Patients Undergoing CAR-T Cell Infusion
Hematologic Malignancy
Идёт набор NCT04892433
Tissue Study in Patients Undergoing CAR-T Cell Therapy (CAR_21_01)
CAR-T Therapy Complications
Идёт набор NCT06071871
A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
Large B-cell Lymphoma
Идёт набор NCT06684639
A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
Neuroblastoma
Идёт набор NCT02954939
The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
Lupus Nephritis
Идёт набор NCT06735495
CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
B-Cell Lymphoblastic Leukemia/Lymphoma
Идёт набор NCT06732492
RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies
NK T-Cell Lymphoma · CART Therapy · CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Идёт набор NCT06732232
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
Relapsed · Refractory · Multiple Myeloma
Идёт набор NCT06733610
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.
Autoimmune Hemolytic Anemia · CD19/BCMA CAR T-cells · Universal Allogeneic CAR T-cells
Идёт набор NCT06728189
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumors
Идёт набор NCT06101381
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
Leukemia, Acute Lymphoblastic · Lymphoma, Non-Hodgkin
Набор скоро начнётся NCT06720701
Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.
Non-Hodgkin Lymphoma
Набор скоро начнётся NCT06721598
An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
Non-Hodgkin Lymphoma, B-cell · Acute Lymphoblastic Leukemia ALL
Идёт набор NCT06720324
CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors
Hematologic Malignancy
Идёт набор NCT06718738
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer
Colorectal Cancer (CRC)
Идёт набор NCT06716164
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research
Non-hodgkin Lymphoma,B Cell
Идёт набор NCT06302062
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
Advanced Solid Tumor · Tumor Associated Lymph Node T Cell · Immunotherapy
Идёт набор NCT06713902
Extracellular Vesicles in Fibrin Gel for Cartilage Repair
Joint Disease
Набор скоро начнётся NCT06690359
IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients
IgA Nephropathy · Membranous Nephropathy
Набор скоро начнётся NCT06705725
Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma
Multiple Myeloma
Идёт набор NCT06698484
To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)
Relapsed/Refractory B- Cell Non-Hodgkin Lymphoma
Набор по приглашению NCT05509855
A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
T-cell Acute Lymphoblastic Leukemia · T-cell Lymphoblastic Lymphoma
Набор по приглашению NCT05859997
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
Systemic Lupus Erythematosus (SLE) · Sjogren's Syndrome · Systemic Sclerosis
Идёт набор NCT03193567
Study of High Efficient Killing Cell Therapy for Advanced NSCLC
Non Small Cell Lung Cancer
Идёт набор NCT06084286
Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors
Advanced Solid Tumor
Набор скоро начнётся NCT06691308
WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
Recurrent or Progressive Glioblastoma
Идёт набор NCT06691152
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Идёт набор NCT06690827
Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN
AML (Acute Myeloid Leukemia) · BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm)
Идёт набор NCT05656573
CART-PSMA Cells for Advanced Prostate Cancer
Prostate Cancer
Идёт набор NCT06686524
Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
Dermatomyositis, Juvenile · Dermatomyositis
Идёт набор NCT06420076
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
T Cell Lymphoma · T Cell Leukemia · T-cell Acute Lymphoblastic Leukemia
Идёт набор NCT06532799
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
Stomach Cancer · Stomach Cancer Recurrent · Stomach Cancer, Adenocarcinoma
Идёт набор NCT06420063
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
AML · Acute Myeloid Leukemia · AML, Adult Recurrent
Идёт набор NCT06532812
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Breast Cancer · Breast Carcinoma · Breast Cancer Metastatic
Набор скоро начнётся NCT06633042
The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD
Autoimmune Disease
Набор скоро начнётся NCT06681337
Universal CAR-T Cell Therapy for Refractory Lupus Nephritis
Lupus Nephritis
Идёт набор NCT05141474
Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors
Epithelial Tumors, Malignant · Malignant Solid Tumor
Идёт набор NCT06461624
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Идёт набор NCT06640582
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Brain Tumor · Brain Metastases · Brain Cancer
Идёт набор NCT06428188
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Autoimmune Diseases · Systemic Lupus Erythematosus · Systemic Lupus Erythematosus Acute
Идёт набор NCT06608732
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
B-cell Acute Lymphoblastic Leukemia
Набор скоро начнётся NCT06646666
ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
B-cell Non Hodgkin Lymphoma
Идёт набор NCT04684459
Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors
Peritoneal Carcinoma Metastatic · Pleural Effusion, Malignant · HER2 Positive Malignancies
Набор скоро начнётся NCT06661811
A Study of CAR-T Cells Targeting Autoimmune Diseases
Autoimmune Diseases
Идёт набор NCT06574126
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
High Risk Smoldering Multiple Myeloma
Набор скоро начнётся NCT06659770
A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Идёт набор NCT06011486
Expansion of Virus-Specific Lymphocytes for Cell Therapy
CMV Viremia · CMV
Идёт набор NCT06589089
Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
Diffuse Large B Cell Lymphoma
Идёт набор NCT05312801
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
Lymphoma, Non-Hodgkin Lymphoma, B-Cell
Набор скоро начнётся NCT06647329
CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors
CAR-T Cell Therapy · Lymphomas
Идёт набор NCT06644443
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
Multiple Myeloma in Relapse
Набор скоро начнётся NCT06641453
CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Идёт набор NCT06609304
Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
Lymphoma, B-Cell
Идёт набор NCT06642025
EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) · CAR-T
Идёт набор NCT06350110
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus · Lupus Nephritis · Autoimmune Diseases
Идёт набор NCT06538012
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Lung Cancer · Lung Cancer Metastatic · Lung Cancer, Non-small Cell
Набор скоро начнётся NCT06641024
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
Acute Lymphoblastic Leukemia, in Relapse · Refractory Acute Lymphoblastic Leukemia
Идёт набор NCT06635330
Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Relapse/Refractory B-cell Acute Lymphoblastic Leukemia
Идёт набор NCT06633354
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
T-Acute Lymphoblastic Leukemia
Идёт набор NCT06633328
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
Aplastic Anemia
Идёт набор NCT04576169
Trial Comparing Treatment Strategies in Triangular Fibrocartilage Complex Ruptures
Triangular Fibrocartilage Complex Injury
Идёт набор NCT06633341
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
T-lymphoblastic Lymphoma
Идёт набор NCT06250816
The Effects of Wearing Operation Gown With Cartoon Characters on Reducing Preoperative Anxiety in Children: Randomized Controlled Study
Anxiety, Preoperative
Набор скоро начнётся NCT06631040
Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL
Acute Lymphocytic Leukemia in Relapse
Набор скоро начнётся NCT06619886
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
Solid Tumor, Adult · Lung Adenocarcinoma · Pancreas Cancer
Идёт набор NCT06617000
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
HCC · Hepatitis B Virus Related Hepatocellular Carcinoma · Hepatocellular Carcinoma
Идёт набор NCT05988216
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Набор по приглашению NCT06616727
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
Recurrent Glioblastoma Multiforme (GBM)
Идёт набор NCT06614686
U87 CAR-T in Patients With Advanced Head and Neck Tumors
Nasopharynx Cancer · Head and Neck Cancer
Идёт набор NCT06238648
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Primary Mediastinal Large B-Cell Lymphoma · Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Идёт набор NCT06612372
Effects of 60-day-6° Head-down Bed Rest on Cartilage and Function of the Knee Joint
Cartilage Degeneration · Weightlessness
Идёт набор NCT06581640
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
Multiple Myeloma · Relapsed/Refractory
Идёт набор NCT06608342
Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia ALL
Идёт набор NCT05641428
Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL
NHL · DLBCL - Diffuse Large B Cell Lymphoma
Набор скоро начнётся NCT06594211
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
Multiple Myeloma
Идёт набор NCT05831033
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
Solid Tumor
Идёт набор NCT06593145
CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms
Acute Lymphoblastic Leukemia (ALL) · Mantle Cell Lymphoma (MCL) · Large B-cell Lymphoma
Набор скоро начнётся NCT06590545
Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis
ANCA-IgG-positive ANCA Associated Vasculitis
Идёт набор NCT06532643
Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma
Relapsed/Refractory Lymphoma
Идёт набор NCT06450067
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
B-cell Acute Lymphoblastic Leukemia
Идёт набор NCT06585345
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia
Acute-Leukemia
Идёт набор NCT05333302
Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma
B-cell Acute Lymphoblastic Leukemia · Lymphoblastic B-Cell Lymphoma
Идёт набор NCT06569472
Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
Juvenile Dermatomyositis